Top

Published in:

Open Access 01-12-2024 | Research

Cognitive changes in people with diabetes with lower extremity complications compared to people with diabetes without lower extremity complications: a systematic review and meta-analysis

Authors: Nimantha Karunathilaka, Christina Parker, Peter A. Lazzarini, Pamela Chen, Chloe Katsanos, Margaret MacAndrew, Kathleen Finlayson

Published in: BMC Endocrine Disorders | Issue 1/2024

Abstract

Background

Recent evidence suggests that diabetes-related lower-extremity complications (DRLECs) may be associated with cognitive changes in people with diabetes. However, existing literature has produced inconsistent findings, and no systematic reviews have been conducted to investigate whether DRLECs impact the cognition of people with diabetes. This systematic review evaluated existing studies that investigated cognition in people with diabetes with DRLECs and without DRLECs.

Method

Seven databases; MEDLINE, PubMed, CINAHL, EMBASE, Cochrane, PsycINFO and Web of Science were searched from inception until 22/8/2022 for studies that compared cognition in people with diabetes with and without DRLECs. Results were independently screened for eligibility and assessed for methodological quality by two authors, with key data extracted. Studies were eligible for meta-analysis if the studies reported similar cases, controls, and outcome measures.

Results

Thirteen studies were included in the review, with eleven of medium methodological quality, one of high quality, and one of low quality. Four studies found significant differences in cognition between those with and without DRLECs, four found significant associations between diabetes-related lower-extremity complications and cognition, and five found no differences or associations. One small meta-analysis of eligible studies found that there was no statistically significant difference in cognition in people without, compared to with, peripheral neuropathy (Mean difference = -0.49; 95%CI: -1.59–0.61; N = 3; n = 215). Leave-one-out sensitivity analyses further confirmed that there was no significant difference in cognition among people with and without peripheral neuropathy (p > 0.05).

Conclusion

DRLECs may be related to cognition in people with diabetes, however, existing evidence is unclear due to variability in used methodologies that may challenge concluding the findings. Future high-quality studies investigating cognition among people with and without DRLECs are needed.

Available only for authorised users

Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–22. https://doi.org/10.1038/nrendo.2016.105.CrossRefPubMed

Wu W, Qiu J, Wang A, Li Z. Impact of whole cereals and processing on type 2 diabetes mellitus: a review. Crit Rev Food Sci Nutr. 2020;60(9):1447–74. https://doi.org/10.1080/10408398.2019.1574708.CrossRefPubMed

Riandini T, Pang D, Toh MPHS, Tan CS, Liu DYK, Choong AMTL, et al. Diabetes-related lower extremity complications in a multi-ethnic Asian population: a 10 year observational study in Singapore. Diabetologia. 2021;64(7):1538–49. https://doi.org/10.1007/s00125-021-05441-3.CrossRefPubMedPubMedCentral

WHO. Gobal Reports on Diabetes World Health Organisation 2016.

Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabet Med. 2018. https://doi.org/10.1111/dme.13680.CrossRefPubMed

Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020;43(5):964–74. https://doi.org/10.2337/dc19-1614.CrossRefPubMed

Kim HG. Cognitive dysfunctions in individuals with diabetes mellitus. Yeungnam Univ J Med. 2019;36(3):183–91. https://doi.org/10.12701/yujm.2019.00255.CrossRefPubMedPubMedCentral

Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GEHM, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329–40. https://doi.org/10.1016/s1474-4422(14)70249-2.CrossRefPubMed

Natovich R, Kushnir T, Harman-Boehm I, Margalit D, Siev-Ner I, Tsalichin D, et al. Cognitive dysfunction: part and parcel of the diabetic foot. Diabetes Care. 2016;39(7):1202–7. https://doi.org/10.2337/dc15-2838.CrossRefPubMed

10.

Corbett C, Jolley J, Barson E, Wraight P, Perrin B, Fisher C. Cognition and understanding of neuropathy of inpatients admitted to a specialized tertiary diabetic foot unit with diabetes-related foot ulcers. Int J Low Extrem Wounds. 2019;18(3):294–300. https://doi.org/10.1177/1534734619862085.CrossRefPubMed

11.

Khera T, Rangasamy V. Cognition and pain: A Review. Psychol. 2021;12. https://www.frontiersin.org/article/10.3389/fpsyg.2021.673962

12.

Burkauskas J, Lang P, Bunevicius A, Neverauskas J, Buciute-Jankauskiene M, Mickuviene N. Cognitive function in patients with coronary artery disease: a literature review. J Int Med Res. 2018;46(10):4019–31. https://doi.org/10.1177/0300060517751452.CrossRefPubMedPubMedCentral

13.

Sluiman AJ, McLachlan S, Forster RB, Strachan MWJ, Deary IJ, Price JF. Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 diabetes study. Diabetologia. 2022;65(3):467–76. https://doi.org/10.1007/s00125-021-05634-w.CrossRefPubMed

14.

Sun C, Xiao Y, Li J, Ge B, Chen X, Liu H, et al. Nonenzymatic function of DPP4 in diabetes-associated mitochondrial dysfunction and cognitive impairment. Alzheimer’s Dement J Alzheimer’s Assoc. 2022;18(5):966–87. https://doi.org/10.1002/alz.12437.CrossRef

15.

Anita NZ, Zebarth J, Chan B, Wu C-Y, Syed T, Shahrul D, et al. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis. Brain Behav Immun. 2022;100:55–69. https://doi.org/10.1016/j.bbi.2021.11.005.CrossRefPubMed

16.

Siru R, Burkhardt MS, Davis WA, Hiew J, Manning L, Ritter JC, et al. Cognitive impairment in people with diabetes-related foot ulceration. J Clin Med. 2021;10(13). https://doi.org/10.3390/jcm10132808.

17.

Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–45. https://doi.org/10.1016/s2213-8587(20)30118-2.CrossRefPubMed

18.

Li J, Zhang W, Wang X, Yuan T, Liu P, Wang T, et al. Functional magnetic resonance imaging reveals differences in brain activation in response to thermal stimuli in diabetic patients with and without diabetic peripheral neuropathy. PLoS ONE. 2018;13(1):e0190699. https://doi.org/10.1371/journal.pone.0190699.CrossRefPubMedPubMedCentral

19.

Palomo-Osuna J, De Sola H, Duenas M, Moral-Munoz JA, Failde I. Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis. Expert Rev Neurother. 2022;22(3):269–81. https://doi.org/10.1080/14737175.2022.2048649.CrossRefPubMed

20.

Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2(3):246–55. https://doi.org/10.1016/s2213-8587(13)70088-3.CrossRefPubMed

21.

Biessels GJ, Whitmer RA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2020;63(1):3–9. https://doi.org/10.1007/s00125-019-04977-9.CrossRefPubMed

22.

Brognara L, Volta I, Cassano VM, Navarro-Flores E, Cauli O. The association between cognitive impairment and diabetic foot care: role of neuropathy and glycated hemoglobin. Pathophysiol. 2020;27(1):14–27. https://doi.org/10.3390/pathophysiology27010003.CrossRef

23.

Doucet J, Le Floch JP, Bauduceau B, Verny C, Intergroup SS. GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: description of the population at inclusion. Diabetes Metab. 2012;38(6):523–30. https://doi.org/10.1016/j.diabet.2012.07.001.CrossRefPubMed

24.

Kloos C, Hagen F, Lindloh C, Braun A, Leppert K, Muller N, et al. Cognitive function is not associated with recurrent foot ulcers in patients with diabetes and neuropathy. Diabetes Care. 2009;32(5):894–6. https://doi.org/10.2337/dc08-0490.CrossRefPubMedPubMedCentral

25.

Marseglia A, Xu W, Rizzuto D, Ferrari C, Whisstock C, Brocco E, et al. Cognitive functioning among patients with diabetic foot. J Diabetes Complications. 2014;28(6):863–8. https://doi.org/10.1016/j.jdiacomp.2014.07.005.CrossRefPubMed

26.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.CrossRefPubMedPubMedCentral

27.

Hu, Wang L, Guo Y, Cao Z, Lu Y, Qin H. Study of the risk and preventive factors for progress of mild cognitive impairment to Dementia. Am J Alzheimer’s Dis Other Dement. 2020;35:1533317520925324. https://doi.org/10.1177/1533317520925324.CrossRef

28.

Hong QNPP, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M-P, GF, Nicolau B, O’Cathain A, Rousseau M-C, Vedel I. Mixed methods appraisal tool (MMAT) vRoC, Canadian, Intellectual Property Office IC.

29.

McCann E, Brown M, Hollins-Martin C, Murray K, McCormick F. The views and experiences of LGBTQ + people regarding midwifery care: a systematic review of the international evidence. Midwifery. 2021;103:103102. https://doi.org/10.1016/j.midw.2021.103102.CrossRefPubMed

30.

McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV. Chapter 9: summarizing study characteristics and preparing for synthesis. Cochrane; 2021. www.training.cochrane.org/handbook.

31.

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805. https://doi.org/10.1177/0962280216669183.CrossRefPubMed

32.

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.org/10.1186/1471-2288-14-135.CrossRefPubMedPubMedCentral

33.

Ding X, Fang C, Li X, Cao Y-J, Zhang Q-L, Huang Y, et al. Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study. BMC Endocr Disord. 2019;19(1):34. https://doi.org/10.1186/s12902-019-0359-2.CrossRefPubMedPubMedCentral

34.

Zhang D, Huang Y, Gao J, Lei Y, Ai K, Tang M, et al. Altered functional topological organization in type-2 diabetes mellitus with and without microvascular complications. Front Neurosci. 2021;15. https://doi.org/10.3389/fnins.2021.726350.

35.

Zhao L, Mao L, Liu Q, Chen X, Tang X, An D. Cognitive impairment in type 2 diabetes patients with and without diabetic peripheral neuropathy: a mismatch negativity study. NeuroReport. 2021;32(14):1223–8. https://doi.org/10.1097/wnr.0000000000001716.CrossRefPubMed

36.

Perlmuter LC, Hakami MK, Hodgson-Harrington C. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med. 1984;77(6):1043–8. https://doi.org/10.1016/0002-9343(84)90186-4.CrossRefPubMed

37.

El-Tamawy MS, Darwish MH, Mohamed SS, Hegazy M, Basheer MA. Influence of cognitive dysfunction on spatiotemporal gait parameters in patients with diabetic polyneuropathy. Egypt J Neurol Psychiatr Neurosurg. 2016;53(4):253–7. https://doi.org/10.4103/1110-1083.202387.CrossRef

38.

Brismar T, Maurex L, Cooray G, Juntti-Berggren L, Lindström P, Ekberg K, et al. Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology. 2007;32(8):1041–51. https://doi.org/10.1016/j.psyneuen.2007.08.002.CrossRefPubMed

39.

Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for diabetic encephalopathy. Diabet Med. 1991;8(2):162–7. https://doi.org/10.1111/j.1464-5491.1991.tb01564.x.CrossRefPubMed

40.

de Bresser J, Reijmer YD, van den Berg E, Breedijk MA, Kappelle LJ, Viergever MA, et al. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord. 2010;30(5):381–6. https://doi.org/10.1159/000321354.CrossRefPubMed

41.

Althubaity SK, Lodhi FS, Khan AA. Frequency and determinants of mild cognitive impairment among diabetic type II patients attending a secondary care hospital in Makkah, Saudi Arabia. Clin Anal Med. 2021;12(3):332–6. https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02274979/full.CrossRef

42.

Blanquisco L, Abejero JE, Buno Ii B, Trajano-Acampado L, Cenina A, Santiago D. Factors associated with mild cognitive impairment among elderly filipinos with type 2 diabetes mellitus. J Asean Fed Endocr Soc. 2017;32(2):145–50. https://doi.org/10.15605/jafes.032.02.08.CrossRefPubMedPubMedCentral

43.

Roman de Mettelinge T, Delbaere K, Calders P, Gysel T, Van Den Noortgate N, Cambier D. The impact of peripheral neuropathy and cognitive decrements on gait in older adults with type 2 diabetes mellitus. Arch Phys M. 2013;94(6):1074–9. https://doi.org/10.1016/j.apmr.2013.01.018.CrossRefPubMed

44.

Moreira RO, Soldera AL, Cury B, Meireles C, Kupfer R. Is cognitive impairment associated with the presence and severity of peripheral neuropathy in patients with type 2 diabetes mellitus? Diabetol Metab Syndr. 2015;7:51. https://doi.org/10.1186/s13098-015-0045-0.CrossRefPubMedPubMedCentral

45.

Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer’s disease clinical trials. Alzheimers Dement (N Y). 2019;5:354–63. https://doi.org/10.1016/j.trci.2019.06.005.CrossRefPubMed

46.

Ojo O, Brooke J. Evaluating the association between diabetes, cognitive decline and dementia. Int J Environ Res Public Health. 2015;12(7):8281–94. https://doi.org/10.3390/ijerph120708281.CrossRefPubMedPubMedCentral

47.

Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. https://doi.org/10.1038/s41574-018-0048-7.CrossRefPubMedPubMedCentral

48.

Omura T, Tamura Y, Sakurai T, Umegaki H, Iimuro S, Ohashi Y, et al. Functional categories based on cognition and activities of daily living predict all-cause mortality in older adults with diabetes mellitus: the Japanese Elderly diabetes intervention trial. Geriatr Gerontol Int. 2021;21(6):512–8. https://doi.org/10.1111/ggi.14171.CrossRefPubMed

49.

Li W, Huang E, Gao S. Type 1 diabetes mellitus and cognitive impairments: a systematic review. J Alzheimer’s Dis. 2017;57:29–36. https://doi.org/10.3233/JAD-161250.CrossRef

50.

Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. https://doi.org/10.1016/0022-3956(75)90026-6.CrossRefPubMed

51.

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.CrossRefPubMed

52.

Grace J, Nadler JD, White DA, Guilmette TJ, Giuliano AJ, Monsch AU, et al. Folstein vs modified mini-mental state examination in geriatric stroke: Stability, validity, and screening utility. Arch Neurol. 1995;52(5):477–84. https://doi.org/10.1001/archneur.1995.00540290067019.CrossRefPubMed

53.

Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36(3–4):242–50. https://doi.org/10.1159/000351671.CrossRefPubMed

54.

Bentvelzen A, Aerts L, Seeher K, Wesson J, Brodaty H. A comprehensive review of the quality and feasibility of dementia assessment measures: the dementia outcomes measurement suite. J Am Med Dir Assoc. 2017;18(10):826–37. https://doi.org/10.1016/j.jamda.2017.01.006.CrossRefPubMed

55.

Au B, Dale-McGrath S, Tierney MC. Sex differences in the prevalence and incidence of mild cognitive impairment: a meta-analysis. Ageing Res Rev. 2017;35:176–99. https://doi.org/10.1016/j.arr.2016.09.005.CrossRefPubMed

56.

Vatanabe IP, Pedroso RV, Teles RHG, Ribeiro JC, Manzine PR, Pott-Junior H, et al. A systematic review and meta-analysis on cognitive frailty in community-dwelling older adults: risk and associated factors. Aging Ment Health. 2022;26(3):464–76. https://doi.org/10.1080/13607863.2021.1884844.CrossRefPubMed

57.

Lipnicki DM, Makkar SR, Crawford JD, Thalamuthu A, Kochan NA, Lima-Costa MF, et al. Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: a COSMIC collaboration cohort study. PLoS Med. 2019;16(7):e1002853. https://doi.org/10.1371/journal.pmed.1002853.CrossRefPubMedPubMedCentral

58.

Jia P, Lee HWY, Chan JYC, Yiu KKL, Tsoi KKF. Long-term blood pressure variability increases risks of dementia and cognitive decline: a meta-analysis of longitudinal studies. J Hypertens. 2021;78(4):996–1004. https://doi.org/10.1161/HYPERTENSIONAHA.121.17788.CrossRef

59.

Ou Y-N, Tan C-C, Shen X-N, Xu W, Hou X-H, Dong Q, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. J Hypertens. 2020;76(1):217–25. https://doi.org/10.1161/HYPERTENSIONAHA.120.14993.CrossRef

60.

Liu Y, Zhong X, Shen J, Jiao L, Tong J, Zhao W, et al. Elevated serum TC and LDL-C levels in Alzheimer’s disease and mild cognitive impairment: a meta-analysis study. Brain Res. 2020;1727:146554. https://doi.org/10.1016/j.brainres.2019.146554.CrossRefPubMed

61.

Álvarez-Bueno C, Cavero-Redondo I, Bruno RM, Saz-Lara A, Sequí-Dominguez I, Notario-Pacheco B, et al. Intima media thickness and cognitive function among adults: meta-analysis of observational and longitudinal studies. J Am Heart Assoc. 2022;11(5):e021760. https://doi.org/10.1161/JAHA.121.021760.CrossRefPubMedPubMedCentral

62.

Anbar R, Sultan SR, Al Saikhan L, Alkharaiji M, Chaturvedi N, Hardy R, et al. Is carotid artery atherosclerosis associated with poor cognitive function assessed using the Mini-mental State examination? A systematic review and meta-analysis. BMJ open. 2022;12(4):e055131. https://doi.org/10.1136/bmjopen-2021-055131.CrossRefPubMedPubMedCentral

63.

Hudon C, Escudier F, De Roy J, Croteau J, Cross N, Dang-Vu TT, et al. Behavioral and psychological symptoms that predict cognitive decline or impairment in cognitively normal middle-aged or older adults: a meta-analysis. Neuropsychol Rev. 2020;30(4):558–79. https://doi.org/10.1007/s11065-020-09437-5.CrossRefPubMed

64.

Rojer AGM, Ramsey KA, Amaral Gomes ES, D’Andrea L, Chen C, Szoeke C, et al. Objectively assessed physical activity and sedentary behavior and global cognitive function in older adults: a systematic review. Mech Ageing Dev. 2021;198:111524. https://doi.org/10.1016/j.mad.2021.111524.CrossRefPubMed

65.

Hartley P, Gibbins N, Saunders A, Alexander K, Conroy E, Dixon R, et al. The association between cognitive impairment and functional outcome in hospitalised older patients: a systematic review and meta-analysis. Age Ageing. 2017;46(4):559–67. https://doi.org/10.1093/ageing/afx007.CrossRefPubMed

66.

Muiños M, Ballesteros S. Does dance counteract age-related cognitive and brain declines in middle-aged and older adults? A systematic review. Neurosci Biobehav Rev. 2021;121:259–76. https://doi.org/10.1016/j.neubiorev.2020.11.028.CrossRefPubMed

Title: Cognitive changes in people with diabetes with lower extremity complications compared to people with diabetes without lower extremity complications: a systematic review and meta-analysis
Authors: Nimantha Karunathilaka
Christina Parker
Peter A. Lazzarini
Pamela Chen
Chloe Katsanos
Margaret MacAndrew
Kathleen Finlayson
Publication date: 01-12-2024
Publisher: BioMed Central
Published in: BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI: https://doi.org/10.1186/s12902-024-01774-3

Relationship between non-alcoholic fatty liver and progressive fibrosis and serum 25-hydroxy vitamin D in patients with type 2 diabetes mellitus

Open Access
Steatotic Liver Disease
Original Research

The associations of risk of cardiovascular disease with development stages of diabetes in Chinese population: findings from a retrospective cohort study in QuZhou city

Open Access
Prediabetes
Original Research

Development and validation of a nomogram for screening patients with type 2 diabetic ketoacidosis

Open Access
Ketoacidosis
Original Research

Dietary nitrate maintains homeostasis of oxidative stress and gut microbiota to promote flap survival in type 2 diabetes mellitus rats

Open Access
Nitrate
Original Research

Comparative effect of physical health training and psychological training of the theory of reasoned action (TRA) model on the life quality of patients with diabetes in Tehran, Iran: utilization of message texting

Open Access
Original Research

The association between parity and type 2 diabetes mellitus: a cross-sectional, community-based study

Open Access
Diabetes
Original Research

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Background

Method

Results

Conclusion

Please log in to get access to this content